Latest Ischaemic heart disease Stories
The outlook for individuals with type 2 diabetes and coronary artery disease is not as grim as originally believed, according to new Saint Louis University research published in Circulation, the Journal of the American Heart Association.
Previous data have proven that GRK2 inhibition is protective against chronic heart failure.
DOYLESTOWN, Pa., Nov. 9 /PRNewswire/ -- Two products from Prescient Medical -- the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System -- will be featured at the 3rd Annual Canaccord Adams Cardiovascular Conference.
PLYMOUTH, Mass., Oct. 22 /PRNewswire/ -- Harvest Technologies Corp. (www.harvesttech.com) announced today that the Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to commence its BMAC Enhanced CABG Trial.
ROCKVILLE, Md., Oct.
A team of researchers led by Massachusetts General Hospital (MGH) radiologists has developed a computed-tomography-based protocol that identifies both narrowing of coronary arteries and areas of myocardial ischemia â€“ restricted blood flow to heart muscle tissue â€“ giving a better indication of clinically significant coronary artery disease.
Cardiac events are the major cause of morbidity and mortality in patients undergoing non-cardiac surgery, and new guidelines issued today by the European Society of Cardiology address this common and complicated challenge.
Women may have a slightly higher risk of death than men in the 30 days following an acute coronary syndrome (ACS) such as heart attack or unstable angina, according to a new study.
A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS.
- To fire mitraille at.